Zebra Capital Management LLC Meridian Bioscience Inc Transaction History

Zebra Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $917,172 - $1.79 Million	-67,738 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$7.84 - $23.29 $123,691 - $367,446	-15,777 Reduced 18.89%	67,738 $1.58 Million
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $45,902 - $94,771	-8,241 Reduced 8.98%	83,515 $701,000
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $530,011 - $680,292	67,090 Added 271.99%	91,756 $896,000
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $133,982 - $175,478	14,611 Added 145.31%	24,666 $235,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $20,073 - $32,472	-1,845 Reduced 15.5%	10,055 $119,000
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $184,569 - $209,559	11,900 New	11,900 $210,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.